Emulating a Target Trial in Perinatal Pharmacoepidemiology: Challenges and Methodological Approaches-Reference-Cited by-同舟云学术

Emulating a Target Trial in Perinatal Pharmacoepidemiology: Challenges and Methodological Approaches

Published:2023-11-21 Issue:4 Volume:10 Page:275-285
ISSN:2196-2995
Container-title:Current Epidemiology Reports
language:en
Short-container-title:Curr Epidemiol Rep

Author:

Chiodo Sabrina,Tailor Lauren,Platt Robert W.,Wood Mollie E.,Grandi Sonia M.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40471-023-00339-7.pdf

Reference45 articles.

1. Hariton E, Locascio JJ. Randomised controlled trials—the gold standard for effectiveness research. BJOG. 2018;125(13):1716.

2. Caniglia EC, et al. Emulating target trials to avoid immortal time bias–an application to antibiotic initiation and preterm delivery. Epidemiology. 2023;34(3):430–8. This study describes how to emulate a sequence of target trials to avoid immortal time bias, and applies the approach to estimate the safety of antibiotic initiation between 24 and 37 weeks gestation on preterm delivery.

3. Food and Drug Administration (FDA), Pregnant women: scientific and ethical considerations for inclusion in clinical trials guidance for industry. Draft guidance, 2018.

4. Leal LF, et al. The use of the target trial approach in perinatal pharmacoepidemiology: a scoping review protocol. Front Pharmacol. 2022;13:904824.

5. Hernández-Díaz S, et al. Emulating a target trial of interventions initiated during pregnancy with healthcare databases: the example of COVID-19 vaccination. Epidemiology. 34(2):238–46. This study utilizes the target trial framework to provide a step-by-step description of how to use healthcare databases to estimate the effects of interventions initiated during pregnancy.